Dr. Hakanson, an anesthesiologist, has more than 16 years of experience in medical affairs, market access and health economic research. He most recently served as the vice president and head of health economics & outcomes research for U.S. medical and drug regulatory affairs at Novartis. He has also previously worked as vice president of healthcare access at Bristol-Myers Squibb.
Dr. Hakanson is a diplomat of the American Board of Anesthesiology and American Society of Anesthesiologists.
Otonomy is a clinical-stage biopharmaceutical company focusing on the development and commercialization of therapies for diseases and disorders of the ear.
More articles on anesthesia:
Annual & hourly anesthesiologist pay: 8 statistics
Somnia Anesthesia calls for anesthesiologist of the year award nominations
Dr. Julian Gold named mayor of California’s Beverly Hills
